FUSN NASDAQ
Fusion Pharmaceuticals Inc.
1W: +0.5%
1M: +0.5%
3M: +105.2%
1Y: +339.8%
3Y: +164.4%
$21.55
Last traded 2024-06-04 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$82M
-11.6% ▼
Capital Expenditures
$4M
-81.6% ▼
5Y CAGR: +28.2%
Free Cash Flow
-$86M
-13.6% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
-100.0% ▼
Net Change in Cash
$18M
+286.2% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$16M | -$78M | -$81M | -$88M | -$95M |
| Depreciation & Amort. | $290K | $482K | $634K | $909K | $1M |
| Stock-Based Comp. | $618K | $3M | $9M | $11M | $12M |
| Change in Working Capital | $3M | $6M | -$15M | $4M | -$1M |
| Other Non-Cash Items | -$1M | $40M | $12M | $2M | -$222K |
| Operating Cash Flow | -$14M | -$30M | -$76M | -$73M | -$82M |
| — Investing Activities — | |||||
| Capital Expenditures | -$456K | -$1M | -$1M | -$2M | -$4M |
| Acquisitions (Net) | $0 | -$10M | -$39M | -$25M | $39M |
| Investment Purchases | $0 | -$219M | -$172M | -$165M | -$231M |
| Investment Sales | $0 | $10M | $212M | $190M | $192M |
| Other Investing | $0 | $10M | $39M | $25M | -$39M |
| Investing Cash Flow | -$456K | -$210M | $38M | $23M | -$43M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | -$72M | $0 | $1M | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $52M | $266M | $347K | $41M | $142M |
| Financing Cash Flow | $52M | $266M | $347K | $41M | $142M |
| Net Change in Cash | $38M | $25M | -$38M | -$9M | $18M |
| Cash End of Period | $67M | $92M | $55M | $45M | $62M |
| Free Cash Flow | -$14M | -$31M | -$77M | -$75M | -$86M |